Who owns GALMED PHARMACEUTICALS LTD?
- Ticker: GLMD
- CUSIP Number: m47238148
Tip: Access positions for across all investors
Analyze quarterly positions in Galmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galmed Pharmaceuticals stock
Who bought or sold GALMED PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Two Sigma Investments | 80k | $39k | -29% | Mar 2026 |
|
| Jane Street | 16k | $8.1k | 36% | Mar 2026 |
|
| Two Sigma Securities | 12k | $5.9k | -12% | Mar 2026 |
|
| Citadel Advisors | 11k | $5.5k | -70% | Mar 2026 |
|
| XTX Topco | 11k | $8.3k | 100% | Dec 2025 |
|
| UBS Group | 2.5k | $1.2k | 40% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 600.00 | $294.000000 | -33% | Mar 2026 |
|
| Morgan Stanley | 157.00 | $77.118400 | -47% | Mar 2026 |
|
| Wells Fargo & Company | 43.00 | $21.500000 | 378% | Mar 2026 |
|
| TSFG | 17.00 | $0 | 0% | Mar 2026 |
|
| SBI Securities | 16.00 | $8.000000 | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 14.00 | $7.000000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 5.00 | $3.000000 | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 2.00 | $2.000000 | 0% | Dec 2025 |
|
| Zrc Wealth Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Dogwood Wealth Management | 1.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Galmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 32k | $24k |